Jedd Wolchok receives Hearst Foundation Grant

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Jed Wolchok

Jedd Wolchok received a $1 million grant over a three-year period from The William Randolph Hearst Foundation to establish a new immuno-oncology research fellowship at Memorial Sloan Kettering Cancer Center, and support postdoctoral students who are conducting exceptional research in the field of immune-oncology and immunotherapy.

Wolchok is the Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation, chief of the Immuno-Oncology Service, director of the Parker Institute for Cancer Immunotherapy, and associate director of the Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center.

The fellowship program will be a part of the Human Oncology and Pathogenesis Program’s Immuno-Oncology service, led by Wolchok.

Table of Contents

YOU MAY BE INTERESTED IN

Pfizer External Research & Grants’ “Improving Breast Cancer Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa,” powered by EveryGrant, has announced grants totaling more than $900,000 for addressing inequities and improving the quality of breast cancer care in Sub-Saharan Africa.
It started innocuously enough. I looked in the mirror and noticed a pigmented area on my scalp just into the hairline. Like many patients, thoughts started running through my head: “Maybe it’s nothing.” Looking at my Outlook calendar, it was packed morning-to-night with meetings, patients, and travel, so I decided I would get that spot checked out the minute I had “time.” 

In the morning of May 28, presumably before turning off the lights and closing the office door, someone at the now defunct NCI Office of Communications and Public Liaision decided to post a farewell message to the cancer community.  The message, posted on multiple social media accounts, read: We’re taking a pause here - but...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login